Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss
2019 · Modern Pathology · 41 citations
https://doi.org/10.1038/s41379-019-0287-8
J
John Wojcik
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
1.5K
Citations
17
h-index
19
i10-index
John Wojcik is an academic researcher from United States Military Academy. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Neurofibromatosis and Schwannoma Cases & Neuroblastoma Research and Treatments. The author has an h-index of 17, co-authored 54 publications.
ORCID: 0000-0001-5403-3631Papers by this author
worksCoexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy
2022 · Cancer Immunology Research · 14 citations
https://doi.org/10.1158/2326-6066.cir-22-0326
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry ( <u>Part 1A</u> – Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis <u>Part 1B</u> - Regulatory Agencies’ Inputs on Regulated Bioanalysis/BMV)
2025 · Bioanalysis · 5 citations
https://doi.org/10.1080/17576180.2025.2450194
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat